Articles with public access mandates - Dean Anthony LeeLearn more
Not available anywhere: 6
Natural killer cells stimulated with PM21 particles expand and biodistribute in vivo: clinical implications for cancer treatment
JL Oyer, V Pandey, RY Igarashi, SS Somanchi, A Zakari, M Solh, DA Lee, ...
Cytotherapy 18 (5), 653-663, 2016
Mandates: Florida Department of Health, USA
Expanded CD56superbrightCD16+ NK Cells from Ovarian Cancer Patients Are Cytotoxic against Autologous Tumor in a Patient-Derived Xenograft Murine Model
SM Poznanski, T Nham, MV Chew, AJ Lee, JA Hammill, IY Fan, M Butcher, ...
Cancer immunology research 6 (10), 1174-1185, 2018
Mandates: Natural Sciences and Engineering Research Council of Canada
Adoptive immunotherapy with double‐bright (CD56bright/CD16bright) expanded natural killer cells in patients with relapsed or refractory acute myeloid leukaemia …
L Silla, V Valim, A Pezzi, M da Silva, I Wilke, J Nobrega, A Vargas, ...
British Journal of Haematology 195 (5), 710-721, 2021
Mandates: Government of Spain
Genome-wide analysis identified 17 new loci influencing intraocular pressure in Chinese population
L Huang, Y Chen, Y Lin, POS Tam, Y Cheng, Y Shi, B Gong, F Lu, J Yang, ...
Science China Life sciences 62, 153-164, 2019
Mandates: National Natural Science Foundation of China
Cellular engineering and therapy in combination with cord blood allografting in pediatric recipients
MS Cairo, N Tarek, DA Lee, C Delaney
Bone marrow transplantation 51 (1), 27-33, 2016
Mandates: US National Institutes of Health
Protect NIH's DNA advisory committee
ZN Adelman, LM Albritton, K Boris-Lawrie, MJ Buchmeier, P Cannon, ...
Science 362 (6413), 409-410, 2018
Mandates: US National Institutes of Health
Available somewhere: 120
Membrane-bound IL-21 promotes sustained ex vivo proliferation of human natural killer cells
CJ Denman, VV Senyukov, SS Somanchi, PV Phatarpekar, LM Kopp, ...
PloS one 7 (1), e30264, 2012
Mandates: US National Institutes of Health
A foundation for universal T-cell based immunotherapy: T cells engineered to express a CD19-specific chimeric-antigen-receptor and eliminate expression of endogenous TCR
H Torikai, A Reik, PQ Liu, Y Zhou, L Zhang, S Maiti, H Huls, JC Miller, ...
Blood, The Journal of the American Society of Hematology 119 (24), 5697-5705, 2012
Mandates: US National Institutes of Health, Fondazione Telethon, Italy, Lymphoma …
Phase I trials using Sleeping Beauty to generate CD19-specific CAR T cells
P Kebriaei, H Singh, MH Huls, MJ Figliola, R Bassett, S Olivares, B Jena, ...
The Journal of clinical investigation 126 (9), 3363-3376, 2016
Mandates: US National Institutes of Health, Lymphoma Research Foundation, USA
Tuning sensitivity of CAR to EGFR density limits recognition of normal tissue while maintaining potent antitumor activity
HG Caruso, LV Hurton, A Najjar, D Rushworth, S Ang, S Olivares, T Mi, ...
Cancer research 75 (17), 3505-3518, 2015
Mandates: US National Institutes of Health, Lymphoma Research Foundation, USA
Tethered IL-15 augments antitumor activity and promotes a stem-cell memory subset in tumor-specific T cells
LV Hurton, H Singh, AM Najjar, KC Switzer, T Mi, S Maiti, S Olivares, ...
Proceedings of the National Academy of Sciences 113 (48), E7788-E7797, 2016
Mandates: US National Institutes of Health, Lymphoma Research Foundation, USA
Clinical-scale derivation of natural killer cells from human pluripotent stem cells for cancer therapy
DA Knorr, Z Ni, D Hermanson, MK Hexum, L Bendzick, LJN Cooper, ...
Stem cells translational medicine 2 (4), 274-283, 2013
Mandates: US National Institutes of Health
Toward eliminating HLA class I expression to generate universal cells from allogeneic donors
H Torikai, A Reik, F Soldner, EH Warren, C Yuen, Y Zhou, DL Crossland, ...
Blood, The Journal of the American Society of Hematology 122 (8), 1341-1349, 2013
Mandates: US National Institutes of Health
Phase 1 clinical trial using mbIL21 ex vivo–expanded donor-derived NK cells after haploidentical transplantation
SO Ciurea, JR Schafer, R Bassett, CJ Denman, K Cao, D Willis, ...
Blood, The Journal of the American Society of Hematology 130 (16), 1857-1868, 2017
Mandates: US National Institutes of Health
T cells redirected to EphA2 for the immunotherapy of glioblastoma
KKH Chow, S Naik, S Kakarla, VS Brawley, DR Shaffer, Z Yi, N Rainusso, ...
Molecular Therapy 21 (3), 629-637, 2013
Mandates: US National Institutes of Health
Similar transplantation outcomes for acute myeloid leukemia and myelodysplastic syndrome patients with haploidentical versus 10/10 human leukocyte antigen–matched unrelated and …
A Di Stasi, DR Milton, LM Poon, A Hamdi, G Rondon, J Chen, SR Pingali, ...
Biology of Blood and Marrow Transplantation 20 (12), 1975-1981, 2014
Mandates: US National Institutes of Health
Reprogramming CD19-specific T cells with IL-21 signaling can improve adoptive immunotherapy of B-lineage malignancies
H Singh, MJ Figliola, MJ Dawson, H Huls, S Olivares, K Switzer, T Mi, ...
Cancer research 71 (10), 3516-3527, 2011
Mandates: US National Institutes of Health
Manufacture of clinical-grade CD19-specific T cells stably expressing chimeric antigen receptor using Sleeping Beauty system and artificial antigen presenting cells
H Singh, MJ Figliola, MJ Dawson, S Olivares, L Zhang, G Yang, S Maiti, ...
PloS one 8 (5), e64138, 2013
Mandates: US National Institutes of Health, Lymphoma Research Foundation, USA
Antigen presenting cell-mediated expansion of human umbilical cord blood yields log-scale expansion of natural killer cells with anti-myeloma activity
N Shah, B Martin-Antonio, H Yang, S Ku, DA Lee, LJN Cooper, ...
PloS one 8 (10), e76781, 2013
Mandates: US National Institutes of Health
Bioengineering T cells to target carbohydrate to treat opportunistic fungal infection
PR Kumaresan, PR Manuri, ND Albert, S Maiti, H Singh, T Mi, J Roszik, ...
Proceedings of the National Academy of Sciences 111 (29), 10660-10665, 2014
Mandates: US National Institutes of Health, Lymphoma Research Foundation, USA
Publication and funding information is determined automatically by a computer program